Kingston 12 Ganja Corporation, Canada
Scientific Tracks Abstracts: J Neurol Neurophysiol
The history of hemp in Japan is rich and royal. Reigniting this majestic bond is most imperative to the burgeoning global hemp Industry spearheaded by Canada and its legalization of cannabis. "Taima" should now be produced on an industrial scale in the 21st century so Japan spiritual love with the plant can be fully recognize to its potential. According to a published paper in 1916 by the Ise Shrine "jingu Taima" (Cannabis) should be respected as a symbol of God. Shinto and cannabis have history over 10,000 years old with evidence in Fukui as well the many products produced proved it's significant economic strength that should be a focus for Japan developing in the 21st century. Emperor Hirohito promise to his subjects was kept and those 50 farmers have proven victorious for the once 25,000 strong who before 1948 produced the holy herb. The Cannabis Control Law should be changed with all due respect. With the introduction of hempcrete, this new material is the most ideal substance for modern Japan to now explore through scientific earthquake studies. It is stronger than concrete and less expensive to manufacture which makes it a more practical building material in an earthquake prone environment. Most patents for hemp are being obtained by China who is now the main producer of the materials imported into the country. Cannabis is the fuel of the future and Japan has a role historically cemented to lead the world. A bill to decriminalize cannabis has been presented in the American Senate and Japan should start consider a process of approach to change in the same way.
Mark Pinnock is a leading Cannabis Philosopher and Activist for 25 years with a keen knowledge in the field. He has published many works in the world of cannabis through his Yukari Mark Publishing Company and is regarded as a Chief Architect of its social acceptance in Canada for the last 20 years. He is the CEO of The Cannabis Lifestyle Brand Kingston 12 Ganja and a micro License Producer (LP) applicant with Health Canada.
E-mail: [email protected]